Whitegate Investment Counselors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-2,567
Closed -$593K 143
2021
Q3
$593K Buy
2,567
+700
+37% +$173K 0.08% 147
2021
Q2
$429K Hold
1,867
0.06% 171
2021
Q1
$349K Hold
1,867
0.05% 174
2020
Q4
$315K Hold
1,867
0.05% 172
2020
Q3
$276K Sell
1,867
-49
-3% -$7.58K 0.05% 173
2020
Q2
$315K Buy
1,916
+49
+3% +$7.52K 0.06% 161
2020
Q1
$259K Hold
1,867
0.06% 156
2019
Q4
$245K Hold
1,867
0.04% 182
2019
Q3
$209K Hold
1,867
0.04% 187
2019
Q2
$207K Hold
1,867
0.04% 186
2019
Q1
$242K Hold
1,867
0.05% 173
2018
Q4
$216K Buy
+1,867
New +$209K 0.05% 178

Other funds holding LLY

Whitegate Investment Counselors's LLY Position: Q4 2021 in Review

Whitegate Investment Counselors sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 2,567 shares — an estimated $593K sold.

Whitegate Investment Counselors first reported a position in LLY in Q4 2018 and held it in 12 quarters. The position peaked at $593K in Q3 2021. 2,303 funds tracked by Wall St. Rank hold LLY as of Q4 2021.

  • Whitegate Investment Counselors reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
  • Whitegate Investment Counselors sold 2,567 Eli Lilly shares in Q4 2021, an estimated $593K.
  • Whitegate Investment Counselors first reported a position in Eli Lilly in Q4 2018 and held it in 12 quarters.
  • Whitegate Investment Counselors's Eli Lilly position peaked at $593K in Q3 2021.
  • 2,303 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.

Based on Whitegate Investment Counselors's 13F filing for Q4 2021, filed 3 Feb 2022.